|
Market Closed -
Nasdaq
04:00:00 2026-10-30 pm EDT
|
5-day change | 1st Jan Change | ||
| 558.88 USD | +3.50% |
|
+6.67% | +23.28% |
| Oct. 30 | UK Healthcare Regulator OKs Vertex Pharmaceuticals' Casgevy Gene Therapy for Children From Age Five | MT |
| Oct. 30 | Vertex Pharmaceuticals Says UK Approves Casgevy for Children Aged 5 and Older | MT |
ETFs positioned on Vertex Pharmaceuticals Incorporated
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +10.83% | - | 44,934 M€ | |
| +16.80% | - | 35,761 M€ | |
| +11.38% | - | 28 M€ | |
| +7.25% | - | 33 M€ | |
| +13.14% | - | 33 M€ | |
| +4.24% | - | 37 M€ | |
| -3.28% | - | 49 M€ | |
| +11.78% | - | 66 M€ | |
| +9.73% | - | 67 M€ | |
| +9.17% | - | 75 M€ | |
| +3.70% | - | 80 M€ | |
| +11.87% | - | 122 M€ | |
| +2.00% | - | 293 M€ | |
| +9.40% | - | 27,154 M€ | |
| +16.47% | - | 750 M€ | |
| +14.11% | - | 507 M€ | |
| +2.95% | - | 165 M€ | |
| +16.25% | - | 148 M€ | |
| +37.29% | 9.51% | 15 M€ | |
| +36.31% | 9.43% | 429 M€ | |
| +28.57% | 9.05% | 78 M€ | |
| +28.50% | 9.05% | 1,079 M€ | |
| +28.94% | 8.88% | 9,953 M€ | |
| +27.38% | 8.54% | 81 M€ | |
| +19.08% | 4.47% | 7 M€ | |
| +18.15% | 4.4% | 28 M€ | |
| +34.32% | 4.33% | 11 M€ | |
| +59.35% | 4.15% | 58 M€ | |
| +53.14% | 4.13% | 87 M€ |
Employees
6,400
Sector
Pharmaceuticals
Calendar
Nov. 02
Earnings release - Q3 2026
- Stock Market
- Stocks
- VRTX Stock
- ETFs Vertex Pharmaceuticals Incorporated
Select your edition
All financial news and data tailored to specific country editions
